Labeling is as critical as quality for medical device products. If a manufacturer can’t shift labeling to meet production in an agile manner, their products may not reach their destination.
We have the opportunity to refine processes that were implemented in a hurry during the pandemic, along with the insight to improve the entire healthcare system.
Among the many lessons from the COVID-19 pandemic, it’s clear that the future of healthcare belongs to those who can harness science and technology—sometimes rapidly—to improve population health through more efficient and accessible care.
It’s time for these companies to bridge the knowledge gap and transform how healthcare information is accessed and used.
In an industry fraught with constant challenges, medtech leaders need to close the growing skills gap of their employee base and develop leadership from within. The pandemic’s impact on an increasingly remote workforce has caused companies to adopt a new approach to cultivating emerging leaders.
Data integration is doing much to enhance regulatory information management. Life sciences companies are increasingly discovering useful interdependencies between data, documents and RIM processes. The next step is to put this data to work to improve efficiency.
Regardless of the reason for disposing of a medical device or other electronic equipment, the product must be destroyed in a manner in which it can never be reused or identified as coming from your organization. In addition, the resulting materials from the destruction process be disposed of in an environmentally appropriate and regulatory compliant manner.
Its success lies in a synergy between the technological and the clinical.
Incorporating bioinformatics platforms can ease the burden of tracking, analyzing and managing the use of antibiotics.
Regenerative medicine unites doctors, scientists, engineers, and others to accelerate healing processes.
